BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wonke B. Clinical management of beta-thalassemia major. Semin Hematol. 2001;38:350-359. [PMID: 11605170 DOI: 10.1016/s0037-1963(01)90029-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Philip J, Jain N. Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient. Asian J Transfus Sci 2014;8:128-30. [PMID: 25161355 DOI: 10.4103/0973-6247.137454] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
2 Zuccato C, Breda L, Salvatori F, Breveglieri G, Gardenghi S, Bianchi N, Brognara E, Lampronti I, Borgatti M, Rivella S, Gambari R. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction. Ann Hematol 2012;91:1201-13. [PMID: 22460946 DOI: 10.1007/s00277-012-1430-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yılmaz K, Kan A, Çetincakmak MG, Uzel VH, Yılmaz D, Deniz MA, Hattapoglu S. Relationship Between Pituitary Siderosis and Endocrinological Disorders in Pediatric Patients with Beta-Thalassemia. Cureus 2021;13:e12877. [PMID: 33633906 DOI: 10.7759/cureus.12877] [Reference Citation Analysis]
4 Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R. Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia. Evid Based Complement Alternat Med 2009;6:141-51. [PMID: 18955291 DOI: 10.1093/ecam/nem139] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
5 Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am 2010;24:1089-107. [PMID: 21075282 DOI: 10.1016/j.hoc.2010.08.003] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
6 Ebrahimisadr P, Bakhshandeh Z, Majidiani H. Red cell alloantibodies in beta-thalassaemia major patients' blood referring to the regional blood transfusion center of Tehran, Iran. Bioimpacts 2021;11:129-33. [PMID: 33842283 DOI: 10.34172/bi.2021.20] [Reference Citation Analysis]
7 Vassiliadis T, Garipidou V, Perifanis V, Tziomalos K, Giouleme O, Patsiaoura K, Avramidis M, Nikolaidis N, Vakalopoulou S, Tsitouridis I, Antoniadis A, Semertzidis P, Kioumi A, Premetis E, Eugenidis N. A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis. World J Gastroenterol 2006;12:818-21. [PMID: 16521204 DOI: 10.3748/wjg.v12.i5.818] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Portincasa P, Moschetta A, Berardino M, Di-Ciaula A, Vacca M, Baldassarre G, Pietrapertosa A, Cammarota R, Tannoia N, Palasciano G. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol 2004;10:2383-90. [PMID: 15285024 DOI: 10.3748/wjg.v10.i16.2383] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
9 Grady RW, Galanello R, Randolph RE, Kleinert DA, Dessi C, Giardina PJ. Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine. Haematologica 2013;98:129-35. [PMID: 22875626 DOI: 10.3324/haematol.2012.070607] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
10 Parise RA, Beumer JH, Kangani CO, Holleran JL, Eiseman JL, Smith NF, Covey JM, Perrine SP, Egorin MJ. Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2008;862:168-74. [PMID: 18155649 DOI: 10.1016/j.jchromb.2007.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
11 Breveglieri G, Mancini I, Bianchi N, Lampronti I, Salvatori F, Fabbri E, Zuccato C, Cosenza LC, Montagner G, Borgatti M, Altruda F, Fagoonee S, Carandina G, Rubini M, Aiello V, Breda L, Rivella S, Gambari R, Finotti A. Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation. Biomed Res Int 2015;2015:687635. [PMID: 26097845 DOI: 10.1155/2015/687635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Gaudio A, Morabito N, Catalano A, Rapisarda R, Xourafa A, Lasco A. Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience. J Clin Res Pediatr Endocrinol 2019;11:110-7. [PMID: 29991466 DOI: 10.4274/jcrpe.galenos.2018.2018.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
13 Cappellini MD. Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag 2007;3:291-9. [PMID: 18360637 DOI: 10.2147/tcrm.2007.3.2.291] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]